Potential Drug–Drug Interactions on a Tertiary-Care Hospital Consultation-Liaison Psychiatry Service
- 31 August 1998
- journal article
- Published by Elsevier in Psychosomatics
- Vol. 39 (4) , 360-365
- https://doi.org/10.1016/s0033-3182(98)71324-6
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Cytochrome P450 EnzymesJournal of Clinical Psychopharmacology, 1996
- Relationship of In Vitro Data on Drug Metabolism to In Vivo Pharmacokinetics and Drug InteractionsJournal of Clinical Psychopharmacology, 1996
- Drug-Drug Interactions Involving Antidepressants: Focus on VenlafaxineJournal of Clinical Psychopharmacology, 1996
- The Clinician and Drug Interactions-An UpdateJournal of Clinical Psychopharmacology, 1996
- Inhibition of Terfenadine Metabolism In Vitro by Azole Antifungal Agents and by Selective Serotonin Reuptake Inhibitor AntidepressantsJournal of Clinical Psychopharmacology, 1996
- Drug Interactions, Cardiac Toxicity, and TerfenadineJournal of Clinical Psychopharmacology, 1996
- Newer antidepressants and the cytochrome P450 systemAmerican Journal of Psychiatry, 1996
- The Emerging Role of Cytochrome P450 3A in PsychopharmacologyJournal of Clinical Psychopharmacology, 1995
- Recent Developments in Drug Metabolism of Relevance to PsychiatristsHarvard Review of Psychiatry, 1994
- An interaction of sertraline and desipramineAmerican Journal of Psychiatry, 1993